Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: emergency  toothache  relief  harvey  aid  cantor  fitzgerald  relief  fund  donation  texas  disaster  charity  multivu  8262751  hunger  food  charity  family  red  gold  help  donation  food  banks  multivu  8111351  deion  sanders  allergan  potox  health  men  beauty  cosmetic  style  multivu  8174251  sanofi  vaccines  health  treatment  fluzone  flu  fda  medical  healthcare  multivu  8081151  st  jude  cancer  health  healthcare  kids  childhood  treatment  research  multivu  7924756  health  medicine  pharmaceuticals  gw  manufacturing  drugs  epileptic  treatment  pills  multivu  8109951  capatriti  olive  oil  food  cooking  meals  health  culinary  healthy  multivu  8077251  fda  pregnant  women  listeriosis  foodborne  disease  health  hispanic  newborn  multivu  7953451  health  sight  blindness  allergan  common  vision  loss  healthcare  prevention  treatment  multivu  8057551  health  pain  treatment  knee  chronic  life  hip  osteoarthritis  surgery  multivu  79644241  photo  social  media  profile  health  overweight  appearance  improvement  treatment  multivu  7962051 
Search // severe
Results 1-12 of 54 for ' severe ' (2 seconds)
Relieve severe toothache with clove oil. It works wonders. The link to buy the oil is: https://amzn.to/2F4hYtK To read the full review please visit: https://bestoralbelectrictoothbrush.com/how-to-treat-a-toothache-with-this-magically-scientific-formula/ There are a couple of home remedies you can try right away to hold off the pain until you get the clove oil. If it persists for longer than a week then go and seek professional help.
Tags // emergency  toothache  relief 
Categories // Miscellaneous 
Added: 95 days ago by johngeltkn
Runtime: 4m35s | Views: 3 | Comments: 2
Not yet rated
 

 

 

Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, announced today that NFL analyst and philanthropist, Deion Sanders, the only athlete to play in both the Super Bowl™ and World Series™, will serve as a brand ambassador for BOTOX® Cosmetic. Harnessing Sanders’ trademark swagger, style and humor, Allergan also released two videos featuring Sanders sharing how he addressed his moderate to severe frown lines and crow’s feet with BOTOX® Cosmetic and showing men everywhere how the treatment may be right for them as well. To view the multimedia release go to: https://www.multivu.com/players/English/8174251-allergan-deion-sanders-botox/
Categories // Miscellaneous 
Added: 344 days ago by MultiVuVideos
Runtime: 5m49s | Views: 4 | Comments: 0
Not yet rated
 

 

 

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of the Fluzone® (Influenza Vaccine) portfolio for the 2017-2018 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA). Sanofi Pasteur has begun distributing initial shipments, representing the first of nearly 70 million total doses of seasonal influenza vaccine manufactured by the company for this upcoming influenza season. Widespread shipment of Fluzone Quadrivalent, Fluzone High-Dose and Fluzone Intradermal Quadrivalent vaccine to health care provider offices, pharmacies and other immunizers will begin in early August to support fall immunization campaigns. “As we enter the Swiftwater site’s 120th year, it reminds us of our innovation and growth as we came to understand the science of influenza and its impact on human health,” said David P. Greenberg, M.D., Associate Vice President and Regional Medical Head North America, Sanofi Pasteur. “Influenza can be especially severe for the most vulnerable populations, including the elderly, young children and those with compromised immune systems; however, it can also have a serious health impact on otherwise healthy individuals. Sanofi Pasteur is and always has been deeply committed to improving public health by continuously striving to develop new vaccines and on improving existing ones.” To view the multimedia release go to: https://www.multivu.com/players/English/8081151-sanofi-pasteur-influenza-vaccine-first-shipment-2017/
Categories // Miscellaneous 
Added: 396 days ago by MultiVuVideos
Runtime: 1m27s | Views: 6 | Comments: 1
Not yet rated
 

 

 

Changes in the treatment of pediatric cancer over recent decades have translated to a reduced risk of serious, long-term late health effects of cancer therapy. This is according to the latest analysis from the Childhood Cancer Survivor Study (CCSS), a National Cancer Institute-funded resource for late-effects research, led by investigators at St. Jude Children’s Research Hospital. “This is the first comprehensive study to demonstrate how changes in treatments over time have impacted the occurrence of late effects experienced by childhood cancer survivors,” said Todd Gibson, Ph.D., assistant member of the Department of Epidemiology and Cancer Control at St. Jude. “We found the 15-year cumulative incidence of people reporting at least one severe health condition decreased from 12.7 percent among childhood cancer survivors diagnosed in the 1970s to 10.1 percent for those diagnosed in the 1980s to 8.8 percent in the 1990s–a statistically significant decline.” To view the multimedia release go to: https://www.multivu.com/players/English/7924756-st-jude-childhood-cancer-survivorship-asco-2017/
Categories // Miscellaneous 
Added: 442 days ago by MultiVuVideos
Runtime: 1m19s | Views: 5 | Comments: 0
Not yet rated
 

 

 

GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, along with its U.S. subsidiary Greenwich Biosciences, announced today that The New England Journal of Medicine has published results from a Phase 3 study of Epidiolex® (cannabidiol) in children with Dravet syndrome.1 Epidiolex, GW’s lead product candidate and the potential first in a new category of anti-epileptic drugs, is a liquid formulation of purified, plant-derived cannabidiol (CBD), a non-psychoactive cannabinoid, which is being studied for the treatment of a number of rare, severe pediatric-onset epilepsy disorders. In the study, Epidiolex significantly reduced monthly convulsive seizure frequency compared to placebo in highly treatment-resistant children when added to existing treatment. Treatment with Epidiolex was generally well tolerated, with a safety profile consistent with prior open label experience. To view the multimedia release go to: https://www.multivu.com/players/uk/8109951-gw-pharmaceuticals-study-epidiolex/
Categories // Miscellaneous 
Added: 449 days ago by MultiVuVideos
Runtime: 3m35s | Views: 2 | Comments: 0
Not yet rated
 

 

 

Capatriti Olive Oil teams up with celebrity chef and owner of “Streets” restaurant in Brooklyn, NY, Roblé Ali, to create viral videos featuring delicious spring and summer themed dishes to benefit celebrity-backed NYC charity organization, God’s Love We Deliver. Consumers can join in on the effort to donate funds toward the amazingly honest and sincere mission of God’s Love We Deliver to help those with severe and chronic illnesses through nutritious meals. Share Capatriti’s Honest Olive Oil campaign videos featuring Chef Roblé on Facebook, Instagram or Twitter and tag @CapatritiOliveOil and #HonestOliveOil. For every share, repost or retweet on social media, Capatriti will donate $1 to God's Love We Deliver, up to $5,000. To view the multimedia release go to: https://www.multivu.com/players/English/8077251-capatriti-gourmet-factory-honest-olive-oil-campaign/
Categories // Miscellaneous 
Added: 451 days ago by MultiVuVideos
Runtime: 3m20s | Views: 5 | Comments: 0
Not yet rated
 

 

 

See America, Allergan’s initiative to fight against preventable blindness in the United States, today unveiled a powerful video featuring award-winning actor and hip-hop artist Common, that urges Americans to “stand in the way of darkness”. The video harnesses Common’s striking spoken word ability, calling on Americans to fight against vision loss and prioritize their vision. Common highlights the 61 million Americans at-risk of severe vision loss, and challenges us all to imagine a life without sight. “I'm proud to join Allergan in the fight against preventable blindness,” said Common. “Sight is something that far too many of us take for granted. I hope our message resonates with people across the country, no matter what age or background.” To view the multimedia release go to: https://www.multivu.com/players/English/8057551-common-joins-allergan-see-america-against-preventable-blindness/
Categories // Miscellaneous 
Added: 522 days ago by MultiVuVideos
Runtime: 1m30s | Views: 8 | Comments: 0
Not yet rated
 

 

 

DePuy Synthes Companies today announced the launch of Hit Play, an educational initiative that encourages those dealing with hip or knee pain to stop settling for a life on ‘pause’ and instead take action to get back to the activities and people they love most. Osteoarthritis is one of the most common reasons for severe hip or knee pain, affecting nearly 27 million Americans today and will potentially affect up to 67 million people by 2030.1,2 In turn, demand for hip and knee replacements are expected to dramatically increase, yet many women see joint replacement as a “last resort” and often wait until the pain has become unbearable before turning to surgery. Through a series of compelling and relatable content, DePuy Synthes seeks to inspire the millions of people stuck on ‘pause’ due to hip or knee pain to explore joint replacement with a doctor, as a potential viable solution when they Hit Play. To view the multimedia release go to: http://www.multivu.com/players/English/79644241-lysol-madison-square-bgca-expose-germs/
Categories // Miscellaneous 
Added: 649 days ago by MultiVuVideos
Runtime: 1m13s | Views: 67 | Comments: 0
Not yet rated
 

 

 

Studies show that more than two-thirds of aesthetically-oriented consumers are bothered by submental fullness, or “double chin.” And with social media profile images becoming more important than ever, there is interest in looking one’s best. Submental fullness due to fat beneath the chin can impact a broad range of both men and women and because the condition can be genetic and resistant to diet and exercise. But there’s KYBELLA®, the first and only FDA-approved injectable treatment that is available by prescription only, that has been proven to improve the appearance of moderate to severe fat beneath the chin by physically destroying fat cells in the treatment area. In two pivotal clinical studies for KYBELLA®, reductions in submental fat volume were observed more frequently in the KYBELLA® treated group of 514 patients compared to the placebo group (508 patients) as measured by both clinician and patient ratings. In addition, visual and emotional impacts of submental fat (happy, bothered, self-conscious, embarrassed, looking older or overweight) were evaluated using a 6-question survey and 79% of 1 and 2-grade composite responders reported satisfaction after 12 weeks post final treatment compared with 33.6% of patients who received placebo. To view the multimedia release go to: http://www.multivu.com/players/English/7962051-kybella-injectable-double-chin-treatment-campaign/
Categories // Miscellaneous 
Added: 662 days ago by MultiVuVideos
Runtime: 3m40s | Views: 60 | Comments: 1
Not yet rated
 

 

 

Sickle cell disease (SCD) is an inherited, lifelong chronic disorder affecting nearly 100,000 Americans and a growing global health problem that will touch nearly 30 percent more people globally in the next three decades. Though new approaches to managing SCD have led to improvements in diagnosis and supportive care, people living with the disease still have severe complications to overcome. Many are unable to access quality care and are limited by a lack of effective treatment options. In an effort to identify unmet medical needs for people with SCD, the American Society of Hematology (ASH), along with other groups, issued the State of Sickle Cell Disease: 2016 Report, evaluating the disease in four priority areas — access to care, training and professional education, research and clinical trials, and global health. The report shows that significant improvements are needed across all areas and that, though patients are living longer, the system of care needs to change to ensure a better quality of life. To address these challenges, ASH launched the Sickle Cell Disease Coalition along with more than 20 other organizations who are issuing a call to action that will amplify the voice of the SCD community, promote SCD awareness, and transform SCD care both in the United States and around the globe. To view the multimedia release go to: http://www.multivu.com/players/English/7903251-american-society-hematology-sickle-cell-coalition/
Categories // Miscellaneous 
Added: 711 days ago by MultiVuVideos
Runtime: 2m49s | Views: 91 | Comments: 0
Not yet rated
 

 

 

Millions of families will head to the beach this Memorial Day weekend, many without adequate sun protection. As part of a national effort to reduce the incidence of skin cancer, Neutrogena® is kicking off the 2016 Choose Skin Health® Campaign with a video featuring Brand Ambassador Kristen Bell asking moms everywhere to get real with their kids about the importance of sunscreen—and a pledge to donate $1 for every video share to the non-profit Children’s Melanoma Prevention Foundation.* Bell’s video acknowledging the challenges moms face tackling serious topics with their children is frank and funny—but skin health is no laughing matter. The fact that only 39% of women and 14% of men use sunscreen regularly is a health issue of national importance when you consider that just one to two severe sunburns can increase lifetime risk of developing melanoma by 40 percent. The Neutrogena® Choose Skin Health® Campaign was created to change the future of skin health and reduce the risk of skin cancer through education, empowerment, and early detection. This year the brand is developing in-school sun safety programs with the potential to reach 1.6 million students annually with a sun safe behavior curriculum, sponsoring 13,000 free skin cancer screenings annually with charitable partners, and working toward a goal of donating $35 million worth of sunscreen to families in need by the end of 2016. To view the multimedia release go to: http://www.multivu.com/players/English/7847951-neutrogena-choose-skin-health/
Categories // Miscellaneous 
Added: 809 days ago by MultiVuVideos
Runtime: 1m59s | Views: 1062 | Comments: 1
Not yet rated
 

 

 

Adolescents and young adults with a severe inherited immunodeficiency disorder improved following treatment with novel gene therapy developed at St. Jude Children’s Research Hospital and at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The results of this study appear today in the journal Science Translational Medicine. The study involved five males with X-linked severe combined immunodeficiency disease (SCID-X1), also known as “Bubble Boy” disease, who were all treated at NIAID. This inherited disorder involves a mutation in the IL2RG gene that affects males and occurs in 1 of every 50,000 to 100,000 live births, leaving them with little to no immune protection. To view the multimedia release go to: http://www.multivu.com/players/English/7808651-st-jude-gene-therapy-results/
Categories // Miscellaneous 
Added: 849 days ago by MultiVuVideos
Runtime: 1m41s | Views: 141 | Comments: 0
Not yet rated
 

 

 

Page 1 of 5  |  Go to page    Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2018 ClipMoon.com. All rights reserved.